vs

Side-by-side financial comparison of Essex Property Trust (ESS) and Surgery Partners, Inc. (SGRY). Click either name above to swap in a different company.

Surgery Partners, Inc. is the larger business by last-quarter revenue ($885.0M vs $479.6M, roughly 1.8× Essex Property Trust). Essex Property Trust runs the higher net margin — 17.9% vs -1.7%, a 19.6% gap on every dollar of revenue. On growth, Essex Property Trust posted the faster year-over-year revenue change (5.5% vs 2.4%). Over the past eight quarters, Surgery Partners, Inc.'s revenue compounded faster (11.1% CAGR vs 6.0%).

Essex Property Trust is a publicly traded real estate investment trust that invests in apartments in California and in the Seattle metropolitan area.

United Surgical Partners International, Inc. (USPI) is an American ambulatory care company based in Dallas, Texas. It was founded by Don Steen in 1998.

ESS vs SGRY — Head-to-Head

Bigger by revenue
SGRY
SGRY
1.8× larger
SGRY
$885.0M
$479.6M
ESS
Growing faster (revenue YoY)
ESS
ESS
+3.2% gap
ESS
5.5%
2.4%
SGRY
Higher net margin
ESS
ESS
19.6% more per $
ESS
17.9%
-1.7%
SGRY
Faster 2-yr revenue CAGR
SGRY
SGRY
Annualised
SGRY
11.1%
6.0%
ESS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ESS
ESS
SGRY
SGRY
Revenue
$479.6M
$885.0M
Net Profit
$85.7M
$-15.0M
Gross Margin
70.0%
Operating Margin
31.7%
12.5%
Net Margin
17.9%
-1.7%
Revenue YoY
5.5%
2.4%
Net Profit YoY
-71.6%
86.2%
EPS (diluted)
$1.24
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESS
ESS
SGRY
SGRY
Q4 25
$479.6M
$885.0M
Q3 25
$473.3M
$821.5M
Q2 25
$469.8M
$826.2M
Q1 25
$464.6M
$776.0M
Q4 24
$454.5M
$864.4M
Q3 24
$450.7M
$770.4M
Q2 24
$442.4M
$762.1M
Q1 24
$426.9M
$717.4M
Net Profit
ESS
ESS
SGRY
SGRY
Q4 25
$85.7M
$-15.0M
Q3 25
$172.7M
$-22.7M
Q2 25
$231.5M
$-2.5M
Q1 25
$212.8M
$-37.7M
Q4 24
$301.7M
$-108.5M
Q3 24
$125.5M
$-31.7M
Q2 24
$99.0M
$-15.5M
Q1 24
$285.1M
$-12.4M
Gross Margin
ESS
ESS
SGRY
SGRY
Q4 25
70.0%
Q3 25
69.2%
Q2 25
70.7%
Q1 25
69.6%
Q4 24
70.0%
Q3 24
69.5%
Q2 24
70.8%
Q1 24
69.7%
Operating Margin
ESS
ESS
SGRY
SGRY
Q4 25
31.7%
12.5%
Q3 25
44.5%
12.9%
Q2 25
59.5%
13.5%
Q1 25
55.3%
8.0%
Q4 24
67.0%
14.7%
Q3 24
28.6%
7.9%
Q2 24
31.1%
11.1%
Q1 24
31.0%
10.6%
Net Margin
ESS
ESS
SGRY
SGRY
Q4 25
17.9%
-1.7%
Q3 25
36.5%
-2.8%
Q2 25
49.3%
-0.3%
Q1 25
45.8%
-4.9%
Q4 24
66.4%
-12.6%
Q3 24
27.8%
-4.1%
Q2 24
22.4%
-2.0%
Q1 24
66.8%
-1.7%
EPS (diluted)
ESS
ESS
SGRY
SGRY
Q4 25
$1.24
$-0.11
Q3 25
$2.56
$-0.18
Q2 25
$3.44
$-0.02
Q1 25
$3.16
$-0.30
Q4 24
$4.00
$-0.86
Q3 24
$1.84
$-0.25
Q2 24
$1.45
$-0.12
Q1 24
$4.25
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESS
ESS
SGRY
SGRY
Cash + ST InvestmentsLiquidity on hand
$76.2M
$239.9M
Total DebtLower is stronger
$3.6B
Stockholders' EquityBook value
$5.5B
$1.7B
Total Assets
$13.2B
$8.1B
Debt / EquityLower = less leverage
2.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESS
ESS
SGRY
SGRY
Q4 25
$76.2M
$239.9M
Q3 25
$66.0M
$203.4M
Q2 25
$58.7M
$250.1M
Q1 25
$98.7M
$229.3M
Q4 24
$66.8M
$269.5M
Q3 24
$71.3M
$221.8M
Q2 24
$55.2M
$213.5M
Q1 24
$499.0M
$185.2M
Total Debt
ESS
ESS
SGRY
SGRY
Q4 25
$3.6B
Q3 25
$6.4B
$3.5B
Q2 25
$6.4B
$3.5B
Q1 25
$6.8B
$3.4B
Q4 24
$3.3B
Q3 24
$6.4B
$3.1B
Q2 24
$6.2B
$3.0B
Q1 24
$6.6B
$2.8B
Stockholders' Equity
ESS
ESS
SGRY
SGRY
Q4 25
$5.5B
$1.7B
Q3 25
$5.6B
$1.7B
Q2 25
$5.6B
$1.7B
Q1 25
$5.6B
$1.7B
Q4 24
$5.5B
$1.8B
Q3 24
$5.4B
$1.9B
Q2 24
$5.5B
$2.0B
Q1 24
$5.5B
$2.0B
Total Assets
ESS
ESS
SGRY
SGRY
Q4 25
$13.2B
$8.1B
Q3 25
$13.2B
$7.9B
Q2 25
$13.2B
$8.0B
Q1 25
$13.2B
$7.9B
Q4 24
$12.9B
$7.9B
Q3 24
$12.6B
$7.5B
Q2 24
$12.5B
$7.5B
Q1 24
$12.9B
$7.0B
Debt / Equity
ESS
ESS
SGRY
SGRY
Q4 25
2.10×
Q3 25
1.15×
2.00×
Q2 25
1.14×
1.98×
Q1 25
1.22×
1.98×
Q4 24
1.83×
Q3 24
1.18×
1.63×
Q2 24
1.13×
1.56×
Q1 24
1.19×
1.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESS
ESS
SGRY
SGRY
Operating Cash FlowLast quarter
$1.1B
$103.4M
Free Cash FlowOCF − Capex
$90.6M
FCF MarginFCF / Revenue
10.2%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
12.53×
TTM Free Cash FlowTrailing 4 quarters
$195.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESS
ESS
SGRY
SGRY
Q4 25
$1.1B
$103.4M
Q3 25
$342.6M
$83.6M
Q2 25
$216.1M
$81.3M
Q1 25
$281.5M
$6.0M
Q4 24
$1.1B
$111.4M
Q3 24
$316.2M
$65.2M
Q2 24
$218.9M
$82.8M
Q1 24
$314.9M
$40.7M
Free Cash Flow
ESS
ESS
SGRY
SGRY
Q4 25
$90.6M
Q3 25
$63.8M
Q2 25
$57.9M
Q1 25
$-16.7M
Q4 24
$89.1M
Q3 24
$45.0M
Q2 24
$55.9M
Q1 24
$19.7M
FCF Margin
ESS
ESS
SGRY
SGRY
Q4 25
10.2%
Q3 25
7.8%
Q2 25
7.0%
Q1 25
-2.2%
Q4 24
10.3%
Q3 24
5.8%
Q2 24
7.3%
Q1 24
2.7%
Capex Intensity
ESS
ESS
SGRY
SGRY
Q4 25
1.4%
Q3 25
2.4%
Q2 25
2.8%
Q1 25
2.9%
Q4 24
2.6%
Q3 24
2.6%
Q2 24
3.5%
Q1 24
2.9%
Cash Conversion
ESS
ESS
SGRY
SGRY
Q4 25
12.53×
Q3 25
1.98×
Q2 25
0.93×
Q1 25
1.32×
Q4 24
3.54×
Q3 24
2.52×
Q2 24
2.21×
Q1 24
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESS
ESS

Segment breakdown not available.

SGRY
SGRY

Private Insurance$460.5M52%
Government Revenue$368.6M42%
Other$19.8M2%
Self Pay Revenue$19.6M2%
Other Patient Service Revenue Sources$16.5M2%

Related Comparisons